ALT Altimmune, Inc.
Healthcare$2.90-1.02%ClosedMarket Cap: $255.9M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$11.25
Target (Median)
$11.25
Target Range
$2.50 - $20.00
Upside from current price: 287.9%
Rating Distribution
3 Strong Buy6 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-14 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-03-16 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-06 | B. Riley Securities | maintain | Buy | Buy |
| 2025-11-07 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-10-20 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-13 | UBS | maintain | Buy | Buy |
| 2025-08-13 | B. Riley Securities | maintain | Buy | Buy |
| 2025-08-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-07-10 | JMP Securities | maintain | Market Outperform | Market Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.76 | $25.7M | 6 |
| Sun Dec 31 | $-0.89 | $94.1M | 5 |
| Mon Dec 31 | $-0.74 | $68.2M | 1 |
| Tue Dec 31 | $-0.67 | $171.5M | 1 |